Clinical Trial Update: Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME) [Phase 2]

View source ↗

Summary

This clinical trial update reports on a Phase 2 study evaluating pembrolizumab in combination with lenvatinib for efficacy and safety in patients with metastati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• LENVIMA (lenvatinib)

Snippet

Sponsor: Institut Curie | Conditions: Metastatic Uveal Melanoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING